Satellite Symposia Schedule

WEDNESDAY, MAY 3

5:30pm - 7:45pm WSS1 Burning Questions about New and Emerging Injectable Therapies for Type 2 Diabetes: A Hot Topics Presentation
Supported by an educational grant from Novo Nordisk
5:30pm - 7:45pm WSS2 A Town Hall Series on Improving Access to PCSK9 Inhibitors: Issues and Recommendations (Non-CME)
Supported by Amgen, Inc., Sanofi and Regeneron

THURSDAY, MAY 4

5:15am - 7:30am TSS1 Continuous Glucose Monitoring as the Standard of Care: Clinical Outcomes, Improved Access and Non-Adjunctive Use
Supported by an educational grant from Dexcom
5:15am - 7:30am TSS2 Current Landscape in Medullary Thyroid Cancer: Updates for Clinicians
Supported by an educational grant from Genzyme, A Sanofi Company
7:15pm - 9:30pm TSS3 Using Insulin When, Where, and How It's Needed: Type 2 Diabetes Treatment in the Modern Age
Supported by an educational grant from Sanofi US
7:15pm - 9:30pm TSS4 UPDATES ABOUND! Latest and Greatest in Practical Application of Cardiovascular Outcomes for Diabetes Drugs
Supported by an educational grant from AstraZeneca

FRIDAY, MAY 5

5:15am - 7:30am FSS1 Standardized Glucose Reporting - The New EKG for Diabetes?
Supported by an educational grant from Abbott
7:00pm - 9:15pm FSS3 Hypoparathyroidism: Evolving Presentation, Incorporating Guidelines and Optimizing Treatment
Supported by an educational grant from Shire
7:00pm - 9:15pm FSS4 Treatment Advances for Challenging Patients with Type 2 Diabetes: The Role of Emerging Insulin Combinations
Supported by an educational grant from Sanofi